Ligand · 3WY
3WY · 2-methyl-L-prolyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide
3WY, 2-methyl-L-prolyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide (C39 H63 N5 O8, 730.0 g/mol), in the…
- Component
- 3WY
- Formula
- C39 H63 N5 O8
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
3WY in 2 structures; the first of them:
- 4X20 · Discovery of cytotoxic Dolastatin 10 analogs with N-terminal modifications · 3WY B503 · binds GLN11, GLN15, PRO175, LYS176, VAL177, SER178, ASP179, TYR210 and 15 more
- 4X20 · Discovery of cytotoxic dolastatin 10 analogs with N-terminal modifications · 3WY B503 · binds GLN11, GLN15, PRO175, LYS176, VAL177, SER178, ASP179, TYR210 and 15 more
Residues it binds most
PRO 4, ASN 4, GLN 4, TYR 4, VAL 4, THR 4, ARG 4, ASP 4, GLY 4, LYS 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.